Provided by Tiger Trade Technology Pte. Ltd.

vTv Therapeutics

31.18
+1.103.66%
Post-market: 31.180.00000.00%16:10 EDT
Volume:12.84K
Turnover:394.00K
Market Cap:122.79M
PE:-29.53
High:31.18
Open:30.16
Low:30.10
Close:30.08
52wk High:44.00
52wk Low:19.50
Shares:3.94M
Float Shares:2.42M
Volume Ratio:0.49
T/O Rate:0.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0558
EPS(LYR):-3.2022
ROE:-15.80%
ROA:-10.14%
PB:5.76
PE(LYR):-9.74

Loading ...

vTv Therapeutics: Buy Rating Reiterated on Favorable Risk-Reward and Clinical Momentum; $67 Price Target Unchanged

TIPRANKS
·
May 15

Analysts Offer Insights on Healthcare Companies: vTv Therapeutics (VTVT), Waters (WAT) and Alpha Teknova (TKNO)

TIPRANKS
·
May 14

Analyst Maintains Buy on vTv Therapeutics, Reiterates Unchanged $49 Price Target Amid Progress of Cadisegliatin Program

TIPRANKS
·
May 14

vTv Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $45 From $47

THOMSON REUTERS
·
May 14

Analysts Offer Insights on Healthcare Companies: Damora Therapeutics (DMRA) and vTv Therapeutics (VTVT)

TIPRANKS
·
May 14

vTv Therapeutics Expands At-The-Market Share Program Capacity

TIPRANKS
·
May 14

vTv Therapeutics Inc - Increases Class a Common Stock Offered Under Atm Program to Full Amount - SEC Filing

THOMSON REUTERS
·
May 14

vTv Therapeutics boosts share capacity under at-the-market equity sales program

Reuters
·
May 14

vTv Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

vTv Therapeutics Q1 EPS $1.65 Beats $(0.10) Estimate, Sales $36.839M Beat $20.000M Estimate

Benzinga Earnings
·
May 14

vTv Therapeutics reports Q1 EPS $1.65, consensus 21c

TIPRANKS
·
May 14

vTv Therapeutics posts Q1 profit on license payment

Reuters
·
May 14

vTv Therapeutics Q1 FY26 swings to net income of $24.13 million; revenue $36.84 million

Reuters
·
May 14

vTv Therapeutics Q1 Operating Expenses USD 13.576 Million

THOMSON REUTERS
·
May 14

vTv Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
May 11

vTv Therapeutics grants 39,500 inducement stock options at $32 exercise price

Reuters
·
May 09

vTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 09

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
May 09

vTv Therapeutics to present at H.C. Wainwright BioConnect investor conference

Reuters
·
May 07

vTv Therapeutics to Participate in Upcoming May Investor Conferences

GlobeNewswire
·
May 07